John G. Cox
2011
In 2011, John G. Cox earned a total compensation of $2.9M as EVP, Pharmaceutical Operations Technology at Biogen.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,086 |
|---|---|
| Non-Equity Incentive Plan | $463,320 |
| Salary | $476,702 |
| Stock Awards | $1,799,250 |
| Other | $139,817 |
| Total | $2,881,175 |
Cox received $1.8M in stock awards, accounting for 62% of the total pay in 2011.
Cox also received $2.1K of change in pension value and nonqualified deferred compensation earnings, $463.3K in non-equity incentive plan, $476.7K in salary and $139.8K in other compensation.
Rankings
In 2011, John G. Cox's compensation ranked 2,245th out of 10,747 executives tracked by ExecPay. In other words, Cox earned more than 79.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,245 out of 10,747 | 79th |
Division Manufacturing | 797 out of 3,960 | 80th |
Major group Chemicals And Allied Products | 173 out of 1,033 | 83rd |
Industry group Drugs | 100 out of 781 | 87th |
Industry Biological Products, Except Diagnostic Substances | 14 out of 157 | 91st |
Source: SEC filing on April 30, 2014.
Cox's colleagues
We found five more compensation records of executives who worked with John G. Cox at Biogen in 2011.